Most Recent
DePuy class action group member appeals failed challenge to payout
A group member in a class action against Johnson & Johnson unit DePuy has filed an appeal after he lost a challenge to his compensation determination, 12 years after the case settled.
Bayer class action wants to know bill for failed case before deciding on appeal
The plaintiff in an unsuccessful class action against Bayer over its Essure contraceptive device wants to see whether she can avoid paying costs in the case before deciding on whether to appeal the loss.
Tesla hit with class action over self-driving cars
Tesla has been hit with a class action alleging the Elon Musk-owned company misled consumers about the capabilities of its self-driving cars.
Allergan may bring ‘state of the art’ defence in breast implants class action
US drug maker Allergan may defend a class action over recalled textured breast implants by arguing its knowledge of the alleged defects was limited by the state of scientific knowledge at the time the products were made.
Class actions pile up against 3M
3M is now facing two class actions in Victoria, after being hit with a case on behalf of ADF members who claim they suffered hearing loss from using defective combat earplugs.
New class action says 3M sold hazardous PFAS products
Chemical manufacturer 3M is facing a class action alleging it sold products containing hazardous materials known as PFAS without disclosing the risks they posed. 
Class action can peek at any settlement offers to Land Rover owners
Jaguar Land Rover can't make an offer to settle the claims of unrepresented group members in a class action over alleged faulty filter systems until after it provides a copy of the offer to solicitors representing the class.
Johnson & Johnson hit with class action over ‘carcinogenic’ baby powder
Healthcare giant Johnson & Johnson is facing a new class action alleging it sold talcum powder that was contaminated with asbestos and caused reproductive system cancers in women.
Monsanto’s condition on Roundup class action discontinuance unfair, judge says
A judge has discontinued a second class action against Monsanto over its Roundup weed killer, but rejected the company's bid for an order that group members be barred from bringing similar claims.
‘Considerable disquiet’: Pelvic mesh group members can challenge $405M settlements
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.